# Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

> **NCT00841399** · PHASE1 · COMPLETED · sponsor: **COL George Peoples, MD, FACS** · enrollment: 100 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** E75 + GM-CSF vaccine

## Key facts

- **NCT ID:** NCT00841399
- **Lead sponsor:** COL George Peoples, MD, FACS
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2012-09
- **Final completion:** 2013-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841399, "Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00841399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*